Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjogren's syndrome

Bowman, Simon J., Everett, Colin C., O'Dwyer, John L., Emery, Paul, Pitzalis, Costantino, Ng, Wan‐Fai, Pease, Colin T., Price, Elizabeth J. +15 more·2017·Arthritis & Rheumatology
DOI 10.1002/art.40093

Cited by (276)

Items 201–276 of 276

  1. Investigative biological therapies for primary Sjögren’s syndrome
    Shi‐Hao He, Yi-Yi Xuan, Xu Liang, Kuang-Jin Guo, Yan Wang, Xiao-Ning Fu, Tian-Fang Li · 2020 · Archives of Medical Science
  2. CRESS: improving the assessment of disease activity in Sjögren's syndrome
    David Alan Isenberg · 2021 · The Lancet Rheumatology
  3. Pharmacological Management of Sjögren’s Syndrome
    You‐Jung Ha, Yun Jong Lee · 2021 · Springer eBooks
  4. Development and Application of the Placebo Response Model in Clinical Trials for Primary Sjögren’s Syndrome
    ZHI-Zhou Wang, Qingshan Zheng, Hongxia Liu, Lujin Li · 2021 · Frontiers in Immunology
  5. Outcome Measures for Sjögren Disease—Novel Developments and Further Needs
    Robert Wilson, Jaiden Townsend, Ellie Hawkins, Coziana Ciurtin · 2024 · British Journal of Hospital Medicine
  6. Route of Application and Dose Evaluation of Dental Pulp Stem Cells for the Treatment of Sialadenitis Caused by Sjögren’s Syndrome: A Preclinical Study
    Zhihao Du, Lifang Feng, Yu Zhang, Xin Peng, Shan Zhang, Rui Hong Zhao, Jia Lei, Xiaotong Li, Guang‐Yan Yu, Chong Ding · 2025 · Biomedicines
  7. Safety and effectiveness of rituximab therapy in Sjögren’s disease: a PORTRESS – the Portuguese registry of Sjögren’s disease-based study
    Carla Campinho Ferreira, Matilde Bandeira, Roberto Pereira da Costa, Susana Emídio Matias, Ana Catarina Duarte, Carlos Marques Gomes, Bárbara Fernandes Esteves, Anita Cunha, Mariana Santos, Lígia Torres Silva et al. · 2026 · Clinical Rheumatology
  8. Comparative Analysis of Clinical Trials of Biologic Drugs for Patients with Primary Sjögren’s Syndrome
    Carlota Navarro-Joven, Silvia Piunno, Maryia Nikitsina, Carmen San José Méndez, David Alan Isenberg · 2026 · Journal of Clinical Medicine
  9. The Evolving Landscape of CAR T-Cell Therapy in Autoimmune Diseases: A State-of-the-Art Review (2025)
    Changpei Li, H L Liu, Shuyi Liao, Yifan Wang, Geng Yin, Qibing Xie · 2026 · Clinical Reviews in Allergy & Immunology
  10. Fatigue in Sjögren’s Disease - Integrating Biomedical and Psychosocial Aspects: A Narrative Review
    Xinyao Zhou, Jinzhou Chen, Pascal J. Cathébras, Martin Killian · 2026 · Rheumatology and Therapy
  11. From Molecular Pathophysiology to Clinical Trial Design in Sjögren’s Disease: A Three-Axis Framework
    Muhammad Shahnawaz Soyfoo, Julie Sarrand, Christine Delporte · 2026 · International Journal of Molecular Sciences
  12. Spatiotemporal orchestration of the salivary gland immune microenvironment in Sjögren’s disease: a multidimensional framework of epithelial licensing, lymphoid neogenesis, and stromal remodeling
    Shouze Ren, Qiwei Li, Rui Niu, Xixi Liu, Peng Zhou, Xiadong Yang, Hua Liang · 2026 · Frontiers in Immunology
  13. Pathogenesis of Sjögren syndrome
    Alexandre Dumusc, Saba Nayar, Benjamin A. Fisher, Simon Bowman · 2024 · Elsevier eBooks
  14. Das Sjögren-Syndrom im Fokus
    Nadine Zehrfeld, Torsten Witte, Diana Ernst · 2024 · DMW - Deutsche Medizinische Wochenschrift
  15. Multiple sclerosis-like manifestations in systemic autoimmune and inflammatory disorders: an update
    Sylvia Raftopoulou, Ioanna Kapsali, Maria‐Eleftheria Evangelopoulos, Clio P. Mavragani · 2025 · Expert Review of Clinical Immunology
  16. Conduite à tenir devant une sécheresse buccale
    Marie Orliaguet, Jacques‐Olivier Pers, Sylvie Boisramé · 2025 · EMC - Odontologie
  17. Rituximab Utilization Evaluation with Focused on Available Evidence for Off-Labeled Indications
    Maryam Farasatinasab, Sohrab Aghabeigi, Soodeh Ramezaninejad, Atefeh Amouzegar, Behrooz Ghanbari, Nashmin Pakdaman, M Mohebbian M Dadashi N Motamed, Simin Almasi, Nader Rezaie, Somayyeh Nasiripour et al. · 2019 · Journal of Pharmaceutical Care
  18. Primary Sjogren's syndrome in practice of gastroenterologist: difficult issues of diagnosis and treatment (clinical observation)
    Кононова Алла Геннадьевна, Сергей Васильевич Колбасников, Бельдиев Сергей Николаевич, Н О Белова, Oxana Zhirnova · 2020 · Medical alphabet
  19. Quality of life of patients with Sjogren’s disease with ongoing therapy with diseasemodifying antirheumatic drugs
    Eric Gan, Ludmila P. Evstigneeva · 2020 · Medical alphabet
  20. SS-A52 antigen expression in thymic carcinoma accompanied with Sjögren syndrome
    Tomomi Isono, Tomoko Wakasa, Hidenori Kusumoto, Keiji Shimada, Takafumi Ogawa, Hiroyuki Shiono · 2021 · Medicine
  21. Traitements présents et futurs du syndrome sec au cours du syndrome de Gougerot-Sjögren primitif
    Gaëtane Nocturne, Marjolaine Gosset, Antoine Rousseau · 2021 · Revue du Rhumatisme Monographies
  22. Biologics in Sjogren’s Syndrome
    Elizabeth Price · 2022 · Springer eBooks
  23. Why stratification is important in primary Sjögren’s syndrome
    Dennis William Lendrem, Jessica R. Tarn, Alexis Collins, James M. S. Wason, Wan‐Fai Ng · 2022 · Rheumatology International
  24. Sjögren-Syndrom: Rituximab nicht besser als Placebo
    Judith Lorenz · 2017 · Aktuelle Rheumatologie
  25. Translational Research in Sjögren’s Syndrome
    Arjan Vissink, Fred K. L. Spijkervet, F. G. M. Kroese, Hendrika Bootsma · 2018 · Springer eBooks
  26. Systems medicine and salivary gland diseases
    Fred K. L. Spijkervet, Arjan Vissink · 2019 · Elsevier eBooks
  27. Sjögren's syndrome: Challenges of a multifaceted disease
    Jolien F. van Nimwegen · 2020
  28. Approaches to the treatment of Sjogren’s syndrome: recommendations and review of the literature
    Ye.D. Yehudіna, Svitlana Trypilka · 2020 · Ukrainian Therapeutical Journal
  29. On- and off-label use of rituximab in rheumatic diseases
    Gilda Sandri, Carlo Umberto Manzini, Carlo Salvarani · 2021 · Beyond Rheumatology
  30. Fatigue in Sjögren’s syndrome
    Su‐Ann Yeoh, Coziana Ciurtin · 2021
  31. Experimental therapies in primary Sjögren’s syndrome
    Benjamin A. Fisher · 2021
  32. Cardiovascular and lung manifestations of Sjögren’s syndrome
    Sara Carty · 2021
  33. Penatalaksanaan Paripurna Sindrom Sjogren
    Riris Asti Respati, Windy Keumala Budianti · 2021 · Jurnal Kedokteran Meditek
  34. Composite endpoints for Sjögren's Syndrome – Authors' reply
    Liseth de Wolff, Suzanne Arends, Hendrika Bootsma · 2021 · The Lancet Rheumatology
  35. Neuro-Sjögren
    Tabea Seeliger, Nils Prenzler, Torsten Witte, Thomas Skripuletz · 2021 · DGNeurologie
  36. References
    David Machin, Peter M. Fayers, Bee Choo Tai · 2021
  37. Sjögren's Syndrome Dry Eye Disease
    Jeremy N. Nortey, John A. Gonzales · 2022 · Elsevier eBooks
  38. Prise en charge de la sécheresse buccale et oculaire
    Gaëtane Nocturne, Marjolaine Gosset, Antoine Rousseau · 2022 · Revue du Rhumatisme Monographies
  39. Traitements futurs de la maladie de Sjögren
    Raphaèle Séror, Gaëtane Nocturne, Xavier Mariette A · 2022 · Revue du Rhumatisme Monographies
  40. Off-Label Use of Biologics in Rheumatological Disorders
    Sumantro Mondal, Alakendu Ghosh · 2022 · Springer eBooks
  41. The Cost of Living with Sjögren’s
    Simon Bowman, Benjamin Fisher · 2022
  42. Traitements actuels et futurs du Syndrome de Sjögren primitif – un développement ambitieux
    Jacob Ritter, Yidan Chen, Ana‐Luisa Stefanski, Thomas Dörner · 2022 · Revue du Rhumatisme
  43. Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
    Md Yuzaiful Md Yusof, Stefano Alivernini, Katerina Chatzidionysiou · 2022 · Frontiers in Medicine
  44. Biologische Therapie bei systemischem Lupus erythematodes, Antiphospholipid-Syndrom und Sjögren-Syndrom: evidenz- und praxisbasierte Leitlinien
    António Marinho, José Delgado Alves, Jorge Fortuna, Raquel Faria, Isabel Almeida, Glória Alves, João Araújo Correia, Ana Campar, Mariana Brandão, Jorge Crespo et al. · 2024 · Kompass Autoimmun
  45. Zielgerichtete Immuntherapien beim primären Sjögren-Syndrom
    Nadine Zehrfeld, Torsten Witte, Diana Ernst · 2024 · Arthritis und Rheuma
  46. The Place of Monoclonal Antibodies in Rheumatic Diseases: Traditional Rewiew
    Şeydanur AVCI, Alperen CANPOLAT, Elif Çadırcı · 2024 · Journal of Literature Pharmacy Sciences
  47. Sjögren’s disease
    Andreas V. Goules, Aimilios Kaklamanos, Loukas G. Chatzis, Athanasios G. Tzioufas · 2024 · Elsevier eBooks
  48. Physiopathologie (partie 2) – session « Rhumatologues en formation »
    Margaux Moret · 2024 · Revue du Rhumatisme
  49. La stratification transcriptomique prédit la réponse au rituximab, à l’abatacept ou à l’association d’hydroxychloroquine-léflunomide dans 3 essais cliniques randomisés chez les patients atteints de la maladie de Sjögren
    B. Chevet, Valérie Devauchelle‐Pensec, Elena Pontarini, Valentin M. D. Baloche, Michele Bombardieri, Simon Bowman, Michael Barnes, Antoine G. Sreih, Jianjun Liu, S. Kelly et al. · 2024 · Revue du Rhumatisme
  50. Evaluation of effectiveness of long-term therapy with Russian rituximab biosimilar in Sjogren’s disease in real clinical practice
    B. D. Chaltsev, Vladimir Ivanovich Vasilyev, Anna Vasilyevna Torgashina, Yu. I. Khvan, Ekaterina B. Rodionova, E. I. Selifanova, Tatiana N. Safonova, Lyudmila A. Semenova, M. V. Burtseva, Svetlana I. Glukhova · 2025 · Rheumatology Science and Practice
  51. Clinical practice guideline for the treatment of Sjögren’s disease through off-label drug use in China (English edition)
    Yingqian MO, Yang Wenjing, Yingxin Li, Lie Dai · 2025 · Clinical Rheumatology
  52. Sjogren’s disease: myths and reality. Part II
    B. D. Chaltsev, Vladimir Ivanovich Vasilyev, Anna Vasilyevna Torgashina · 2025 · Rheumatology Science and Practice
  53. Additional file 1 of Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study
    Alexandre Dumusc, Fahad Alromaih, Matthieu Perreau, Thomas Hügle, Pascal Zufferey, Dan, Diana · 2023 · Figshare
  54. Additional file 1 of Longitudinal analysis of symptom-based clustering in patients with primary Sjogren’s syndrome: a prospective cohort study with a 5-year follow-up period
    Jennifer Jooha Lee, Park, Young Jae, Park, Misun, Yim, Hyeon Woo, Park, Sung Hwan, Kwok, Seung-Ki · 2021 · Figshare
  55. Low-Grade B-cell Lymphoma in Primary Sjögren’s Syndrome: A Case Report
    Thanda Aung, Giovanni Botten, Anamaria Munteanu, Bita V Naini, Anthony Pastizzo, Kanwarpal S Kahlon · 2025 · Cureus
  56. Efficacy and Safety of SA001 in Patients with Primary Sjögren’s Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
    Jaewon Park, Kyoung Yul Seo, Hyunmin Ahn, Yearim Shin, Ikhyun Jun, Tae-Im Kim, Bumkyu Shin, Dayoung Yoon, Soomin Lee · 2026 · Pharmaceuticals
  57. Effectiveness of biological drugs in the treatment of xerostomia and salivary hypofunction in patients with Sjögren disease
    Juan Manuel Romero, María García-Pola, Alba Bello-Castro, Javier Seoane‐Romero, Pablo Ignacio Varela‐Centelles, Tania Gancedo‐Gancedo, Pablo Castelo‐Baz · 2026 · The Journal of the American Dental Association
  58. Research progress on the application of telitacicept in rheumatism and autoimmune diseases
    Xue Wang, Yihuai Xu, Guixia Tong, Hong Zhang · 2026 · Journal of Zhejiang University (Medical Sciences)
  59. Evaluation of Effectiveness of Long-Term Therapy with Russian Rituximab Biosimilar (Acellbia) in Sjogren’s Disease in Real Clinical Practice
    B. D. Chaltsev, V. I. Vasilyev, Anna Vasilyevna Torgashina, Yu. I. Khvan, E B Rodionova, E. I. Selifanova, T. N. Safonova, L. A. Semenova, M. V. Burtseva, S. I. Glukhova · 2026 · Doklady Biochemistry and Biophysics
  60. Rôle des cellules épithéliales salivaires au cours du Syndrome de Sjögren primitif
    Élodie Rivière · 2020 · theses.fr (ABES)
  61. Aktuelle Therapien, absehbare Newcomer und neue Therapieansätze für die Sjögren-Erkrankung
    Diana Ernst, Nadine Zehrfeld · 2026 · Zeitschrift für Rheumatologie
  62. Sjögren Disease and Immunoglobulin-G4–Related Disease
    Scott M. Lieberman, Coziana Ciurtin · 2026 · Elsevier eBooks
  63. Molecular classification of primary Sjögren’s syndrome based on salivary gland omics
    Wuwei Zhuang, Qiang Zhang, Jie Shen, Lin Zhu, Wenyan Shen, Xinyu Pu, Tingting Yan, Qiao Ye · 2026 · Arthritis Research & Therapy
  64. Age-specific reference values for unstimulated whole saliva flow rate in primary Sjögren’s syndrome: a cross-sectional study
    Yang Yang, Xin-Xiang Huang, Danli Meng, Yijia Huang, Yanting Yang, Rong-Xiu Huo, Ji Lin · 2026 · BMC Oral Health
  65. Janus kinase inhibitor use and incident dry eye disease in rheumatoid arthritis: a real-world cohort study
    Ching-Chieh Lin, Yang-Chi Lin, Renin Chang, Chun‐Yu Lin, J-S Chen · 2026 · Frontiers in Immunology
  66. Integrating basal and reserve salivary function defines clinically anchored functional phenotypes and contextualises salivary end points in Sjögren’s disease
    Chiao‐Feng Cheng, Ting‐Yuan Lan, Jui‐Hung Kao, Tseng‐Cheng Chen, Min‐Shu Hsieh, Yu-Heng Lin, Yi-Min Huang, Yi‐Chieh Chen, M T Cheng, Hsiao-Sang Chu et al. · 2026 · RMD Open
  67. Exploring salivary and lacrimal biomarkers in non-Sjögren sicca: A scoping review
    Fernanda Luiza Araújo de Lima Castro, Mariana Silveira Souza, José Alcides Almeida de Arruda, Victor Zanetti Drumond, Hélène Chardin, Ana Carolina Acevedo, Renata Gonçalves Resende, Débora Cerqueira Calderaro, Sílvia Ferreira de Sousa, Tarcı́lia Aparecida Silva · 2026 · Archives of Oral Biology
  68. From immune activation to symptom burden: mechanisms and translational implications of immune–symptom uncoupling in Sjögren’s disease
    Jingying Le, Bingyan Gu, Zouyin Su, X. Y. Wang · 2026 · Frontiers in Immunology
  69. B-cell centrality dictates therapeutic efficacy across autoimmune diseases: a systematic review
    Vishakha Hooda, Harsh Goel, Taruna Madan, Alpana Sharma · 2026 · Frontiers in Immunology
  70. Immunosuppressive and immunomodulatory therapies in Sjögren’s disease: current landscape and future perspectives
    Veli Yazısız · 2026 · Expert Opinion on Pharmacotherapy
  71. Histone lactylation: a metabolic-epigenetic bridge linking glycolysis to salivary gland fibrosis in Sjögren’s disease
    Qin Yang, Huayan Tang · 2026 · Frontiers in Immunology
  72. Tregs transduced with a Ro60-reactive TCR have increased immunosuppressive functions in Sjögren’s disease
    Zhi Feng Sherman Lim, Rachel M. Y. Cheong, Fabien B. Vincent, Janet Chang, Khai Lee Loh, Hanim Halim, G.K.-W. Kong, Elean S. V. Tay, Cheng Rui Peh, Xiaoyu Jia et al. · 2026 · iScience
  73. Host–Microbe Crosstalk in Sjögren’s Disease: Epithelial Type I Interferon Amplification, Loss of Short-Chain Fatty Acid Restraint, and the Effector-Phase Focus of Validated Therapy
    Minjae Yu, Dahee Jo, Yeonhee Hwang, Kyudong Han · 2026 · International Journal of Molecular Sciences
  74. Biomarkers, clinical outcome assessments and endpoints for studies of salivary gland diseases
    Michael Thomas Brennan, Thomas Fry, Rajesh V. Lalla, Margaret M. Grisius, Blake M. Warner, Jane C. Atkinson · 2026 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
  75. Baminercept in Sjogren's Syndrome (ASJ02)
    E. William St. Clair, Judith James · 2018 · ImmPort
  76. Emerging Drugs
    Brendan Denvir, Thomas Grader‐Beck · 2026 · Rheumatic Disease Clinics of North America